000 01611 a2200493 4500
005 20250516205110.0
264 0 _c20151012
008 201510s 0 0 eng d
022 _a1473-1150
024 7 _a10.1038/tpj.2014.16
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDias, M M
245 0 0 _aThe effect of the UGT1A1*28 allele on survival after irinotecan-based chemotherapy: a collaborative meta-analysis.
_h[electronic resource]
260 _bThe pharmacogenomics journal
_cOct 2014
300 _a424-31 p.
_bdigital
500 _aPublication Type: Journal Article; Meta-Analysis; Systematic Review
650 0 4 _aAlleles
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadministration & dosage
650 0 4 _aCamptothecin
_xadministration & dosage
650 0 4 _aDisease Progression
650 0 4 _aGenotype
650 0 4 _aGlucuronosyltransferase
_xgenetics
650 0 4 _aHumans
650 0 4 _aIrinotecan
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aSurvival Analysis
700 1 _aPignon, J-P
700 1 _aKarapetis, C S
700 1 _aBoige, V
700 1 _aGlimelius, B
700 1 _aKweekel, D M
700 1 _aLara, P N
700 1 _aLaurent-Puig, P
700 1 _aMartinez-Balibrea, E
700 1 _aPáez, D
700 1 _aPunt, C J A
700 1 _aRedman, M W
700 1 _aToffoli, G
700 1 _aWadelius, M
700 1 _aMcKinnon, R A
700 1 _aSorich, M J
773 0 _tThe pharmacogenomics journal
_gvol. 14
_gno. 5
_gp. 424-31
856 4 0 _uhttps://doi.org/10.1038/tpj.2014.16
_zAvailable from publisher's website
999 _c23715624
_d23715624